BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jacobson KA, Giancotti LA, Lauro F, Mufti F, Salvemini D. Treatment of chronic neuropathic pain: purine receptor modulation. Pain 2020;161:1425-41. [PMID: 32187120 DOI: 10.1097/j.pain.0000000000001857] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Yang R, Li Z, Zou Y, Yang J, Li L, Xu X, Schmalzing G, Nie H, Li G, Liu S, Liang S, Xu C. Gallic Acid Alleviates Neuropathic Pain Behaviors in Rats by Inhibiting P2X7 Receptor-Mediated NF-κB/STAT3 Signaling Pathway. Front Pharmacol 2021;12:680139. [PMID: 34512324 DOI: 10.3389/fphar.2021.680139] [Reference Citation Analysis]
2 Magni G, Ceruti S. Adenosine Signaling in Autoimmune Disorders. Pharmaceuticals (Basel) 2020;13:E260. [PMID: 32971792 DOI: 10.3390/ph13090260] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
3 Zhou M, Wu J, Chang H, Fang Y, Zhang D, Guo Y. Adenosine signaling mediate pain transmission in the central nervous system. Purinergic Signal 2022. [PMID: 35000074 DOI: 10.1007/s11302-021-09826-2] [Reference Citation Analysis]
4 Trapero C, Martín-Satué M. Purinergic Signaling in Endometriosis-Associated Pain. Int J Mol Sci 2020;21:E8512. [PMID: 33198179 DOI: 10.3390/ijms21228512] [Reference Citation Analysis]
5 Durante M, Squillace S, Lauro F, Giancotti LA, Coppi E, Cherchi F, Di Cesare Mannelli L, Ghelardini C, Kolar G, Wahlman C, Opejin A, Xiao C, Reitman ML, Tosh DK, Hawiger D, Jacobson KA, Salvemini D. Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10. J Clin Invest 2021;131:139299. [PMID: 33621215 DOI: 10.1172/JCI139299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Dane C, Stokes L, Jorgensen WT. P2X Receptor Antagonists and their Potential as Therapeutics: a patent review (2010 - 2021). Expert Opin Ther Pat 2022. [PMID: 35443137 DOI: 10.1080/13543776.2022.2069010] [Reference Citation Analysis]
7 Lv ZY, Yang YQ, Yin LM. Role of Purinergic Signaling in Acupuncture Therapeutics. Am J Chin Med 2021;49:645-59. [PMID: 33641652 DOI: 10.1142/S0192415X21500294] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 De Marchi E, Pegoraro A, Adinolfi E. P2X7 Receptor in Hematological Malignancies. Front Cell Dev Biol 2021;9:645605. [PMID: 33763425 DOI: 10.3389/fcell.2021.645605] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Salmaso V, Jacobson KA. Purinergic Signaling: Impact of GPCR Structures on Rational Drug Design. ChemMedChem 2020;15:1958-73. [PMID: 32803849 DOI: 10.1002/cmdc.202000465] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
10 He XF, Kang YR, Fei XY, Chen LH, Li X, Ma YQ, Hu QQ, Qu SY, Wang HZ, Shao XM, Liu BY, Yi-Liang, Du JY, Fang JQ, Jiang YL. Inhibition of phosphorylated calcium/calmodulin-dependent protein kinase IIα relieves streptozotocin-induced diabetic neuropathic pain through regulation of P2X3 receptor in dorsal root ganglia. Purinergic Signal 2022. [PMID: 34973115 DOI: 10.1007/s11302-021-09829-z] [Reference Citation Analysis]
11 Muñoz MF, Griffith TN, Contreras JE. Mechanisms of ATP release in pain: role of pannexin and connexin channels. Purinergic Signal 2021. [PMID: 34792743 DOI: 10.1007/s11302-021-09822-6] [Reference Citation Analysis]
12 Zhang WJ, Luo HL, Zhu JF, Hu CG, Zhu ZM. Transplantation of olfactory ensheathing cells combined with chitosan down-regulates the expression of P2X7 receptor in the spinal cord and inhibits neuropathic pain. Brain Res 2020;1748:147058. [PMID: 32888912 DOI: 10.1016/j.brainres.2020.147058] [Reference Citation Analysis]
13 Jacobson KA, Reitman ML. Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs. Cells 2020;9:E956. [PMID: 32295065 DOI: 10.3390/cells9040956] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Coppi E, Cherchi F, Lucarini E, Ghelardini C, Pedata F, Jacobson KA, Di Cesare Mannelli L, Pugliese AM, Salvemini D. Uncovering the Mechanisms of Adenosine Receptor-Mediated Pain Control: Focus on the A3 Receptor Subtype. Int J Mol Sci 2021;22:7952. [PMID: 34360719 DOI: 10.3390/ijms22157952] [Reference Citation Analysis]
15 Yamashita T, Kamikaseda S, Tanaka A, Tozaki-Saitoh H, Caaveiro JMM, Inoue K, Tsuda M. New Inhibitory Effects of Cilnidipine on Microglial P2X7 Receptors and IL-1β Release: An Involvement in its Alleviating Effect on Neuropathic Pain. Cells 2021;10:434. [PMID: 33670748 DOI: 10.3390/cells10020434] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Magni G, Ceruti S. Purines in Pain as a Gliopathy. Front Pharmacol 2021;12:649807. [PMID: 33790798 DOI: 10.3389/fphar.2021.649807] [Reference Citation Analysis]
17 Bozdemir E, Vigil FA, Chun SH, Espinoza L, Bugay V, Khoury SM, Holstein DM, Stoja A, Lozano D, Tunca C, Sprague SM, Cavazos JE, Brenner R, Liston TE, Shapiro MS, Lechleiter JD. Neuroprotective Roles of the Adenosine A3 Receptor Agonist AST-004 in Mouse Model of Traumatic Brain Injury. Neurotherapeutics 2021. [PMID: 34608616 DOI: 10.1007/s13311-021-01113-7] [Reference Citation Analysis]
18 Ceruti S. From astrocytes to satellite glial cells and back: A 25 year-long journey through the purinergic modulation of glial functions in pain and more. Biochem Pharmacol 2021;187:114397. [PMID: 33382970 DOI: 10.1016/j.bcp.2020.114397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Vincenzi F, Pasquini S, Borea PA, Varani K. Targeting Adenosine Receptors: A Potential Pharmacological Avenue for Acute and Chronic Pain. Int J Mol Sci 2020;21:E8710. [PMID: 33218074 DOI: 10.3390/ijms21228710] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
20 Jacobson KA, IJzerman AP, Müller CE. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets. Biochem Pharmacol 2021;187:114311. [PMID: 33130128 DOI: 10.1016/j.bcp.2020.114311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
21 Luongo L, Guida F, Maione S, Jacobson KA, Salvemini D. Adenosine Metabotropic Receptors in Chronic Pain Management. Front Pharmacol 2021;12:651038. [PMID: 33935761 DOI: 10.3389/fphar.2021.651038] [Reference Citation Analysis]